Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-25-000652
Filing Date
2025-02-28
Accepted
2025-02-28 16:48:59
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form412227019nat_02282025.html 4  
1 OWNERSHIP DOCUMENT form412227019nat_02282025.xml 4 4583
  Complete submission text file 0000921895-25-000652.txt   6145
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6720 NW 74TH COURT PARKLAND FL 33067
Business Address
NATAN DAVID (Reporting) CIK: 0001253108 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 25691463